These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck. Johnson JT; Wagner RL; Myers EN Cancer; 1996 Jan; 77(1):181-5. PubMed ID: 8630927 [TBL] [Abstract][Full Text] [Related]
3. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Stolwijk C; Wagener DJ; Van den Broek P; Levendag PC; Kazem I; Bruaset I; De Mulder PH Neth J Med; 1985; 28(9):347-51. PubMed ID: 2413379 [No Abstract] [Full Text] [Related]
4. Chemoradiation for metastatic SCCA: role of comorbidity. Hathaway B; Johnson JT; Piccirillo JF; Snyderman CH; Wagner RL; Labriola S; Myers EN Laryngoscope; 2001 Nov; 111(11 Pt 1):1893-5. PubMed ID: 11801964 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of head and neck cancer]. Kohno N; Nakazawa E; Kusunoki M; Nishiya M Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck. Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320 [TBL] [Abstract][Full Text] [Related]
7. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Katori H; Tsukuda M; Taguchi T Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926 [TBL] [Abstract][Full Text] [Related]
8. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for high-risk squamous-cell carcinoma of the head and neck. Johnson JT; Myers EN; Schramm VL; Mayernik DG; Nolan TA; Sigler BA; Wagner RL J Clin Oncol; 1987 Mar; 5(3):456-8. PubMed ID: 3546619 [TBL] [Abstract][Full Text] [Related]
10. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318 [TBL] [Abstract][Full Text] [Related]
11. Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas. Le QT; Taira A; Budenz S; Jo Dorie M; Goffinet DR; Fee WE; Goode R; Bloch D; Koong A; Martin Brown J; Pinto HA Cancer; 2006 May; 106(9):1940-9. PubMed ID: 16532436 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment with chemotherapy in patients with advanced head and neck cancer. Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck. Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922 [TBL] [Abstract][Full Text] [Related]
15. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck]. Taguchi T; Tsukuda M Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. An interim report from the SECOG participants. South-East Co-operative Oncology Group. Eur J Surg Oncol; 1986 Sep; 12(3):289-95. PubMed ID: 2428668 [TBL] [Abstract][Full Text] [Related]
17. [A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil]. Yamashita S; Hirao M; Tsujinaka T; Sawamura T; Nakamori S; Mishima H; Fujitani K; Ikenaga M; Kashiwazaki M; Masuda N Gan To Kagaku Ryoho; 2005 Aug; 32(8):1149-51. PubMed ID: 16121918 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy]. Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971 [TBL] [Abstract][Full Text] [Related]
19. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer. Campbell JB; Dorman EB; McCormick M; Miles J; Morton RP; Rugman F; Stell PM; Stoney PJ; Vaughan ED; Wilson JA Acta Otolaryngol; 1987; 103(5-6):519-28. PubMed ID: 3303823 [TBL] [Abstract][Full Text] [Related]
20. Management of squamous cell carcinoma of unknown origin in cervical lymph nodes. Mohit-Tabatabai MA; Dasmahapatra KS; Rush BF; Ohanian M Am Surg; 1986 Mar; 52(3):152-4. PubMed ID: 3954261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]